Christine Serratrice

Christine Serratrice is currently working as the Co-Founder and Chief Medical Officer at Atopia Therapeutics, formerly HpVac. Christine also holds the position of CMO at Dorphan SA and Chief Medical Officer at Geneva Biotech Center (GBC) SA. With a background in internal medicine, Christine has previously worked at Hôpitaux Universitaires de Genève and Fondation Hopital Saint Joseph. Christine holds a Doctorat en medecine in Medecine interne from Faculté de Medecine Marseille and has a Diploma of Advanced Studies in Management of clinical trials from the University of Geneva. Additionally, Christine has a DEA in Immunologie from Faculté des sciences de luminy.